Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate Persistent Asthma”

Showing 20 of 0 results

Not applicableStudy completedNCT07787507
What this trial is testing

Withania Somnifera for Moderate-to-Severe Persistent Asthma

Who this might be right for
Asthma
Aligarh Muslim University 120
Post-approval studies (Phase 4)Study completedNCT00480649
What this trial is testing

Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS)

Who this might be right for
Asthma
GlaxoSmithKline 424
Large-scale testing (Phase 3)Study completedNCT03372473
What this trial is testing

Montelukast and Loratadine in Children With Asthma

Who this might be right for
Asthma in Children
Innovacion y Desarrollo de Estrategias en Salud 80
Testing effectiveness (Phase 2)Study completedNCT00189787
What this trial is testing

Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma

Who this might be right for
Asthma, BronchialBronchial Asthma
Astellas Pharma Inc 370
Large-scale testing (Phase 3)Study completedNCT04233190
What this trial is testing

A Multicenter, Randomized, Parallel, Two-Period, Non-Inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment

Who this might be right for
Asthma Copd
Eurofarma Laboratorios S.A. 472
Not applicableStudy completedNCT00784758
What this trial is testing

Fenzian Asthma Multicenter Outcomes Study

Who this might be right for
Asthma
University of California, Los Angeles 81
Testing effectiveness (Phase 2)UnknownNCT00859404
What this trial is testing

A Clinical Study of Oglemilast in Patients With Mild to Moderate Persistent Asthma

Who this might be right for
Asthma
Glenmark Pharmaceuticals Europe Ltd. (R&D) 282
Large-scale testing (Phase 3)Study completedNCT01202903
What this trial is testing

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Who this might be right for
Persistent Allergic Asthma
Novartis Pharmaceuticals 616
Not applicableStudy completedNCT03188120
What this trial is testing

Specific Use-Result of Spiriva Respimat® in Asthmatics

Who this might be right for
Asthma
Boehringer Ingelheim 193
Large-scale testing (Phase 3)Study completedNCT06657066
What this trial is testing

EFFECTIVENESS of PROBIOTICS in ADULTS with MODERATE to SEVERE PERSISTENT ASTHMA

Who this might be right for
Asthma Patients
King Edward Medical University 74
Large-scale testing (Phase 3)Study completedNCT01340209
What this trial is testing

Evaluation of Tiotropium 2.5 and 5 µg Once Daily Delivered Via the Respimat Inhaler Compared to Placebo in Patient With Moderate to Severe Persistent Asthma

Who this might be right for
Asthma
Boehringer Ingelheim 285
Post-approval studies (Phase 4)Study completedNCT00461500
What this trial is testing

SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults

Who this might be right for
Asthma
GlaxoSmithKline 81
Post-approval studies (Phase 4)Study completedNCT00157937
What this trial is testing

Compare Effectiveness of Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics (0476-329)

Who this might be right for
AsthmaAllergic Rhinitis
Organon and Co 31
Large-scale testing (Phase 3)Study completedNCT00529529
What this trial is testing

Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma

Who this might be right for
Asthma
Novartis Pharmaceuticals 805
Not applicableStudy completedNCT00282516
What this trial is testing

Asthma In-Home Monitoring (AIM) Trial

Who this might be right for
Mild, Moderate and Severe Persistent Asthma as Defined by NHLBI-2 Guidelines
Tripler Army Medical Center 120
Testing effectiveness (Phase 2)Study completedNCT00141791
What this trial is testing

Study Evaluating Etanercept in Moderate to Severe Asthma

Who this might be right for
Asthma
Wyeth is now a wholly owned subsidiary of Pfizer 120
Large-scale testing (Phase 3)Study completedNCT00254956
What this trial is testing

Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent Asthma

Who this might be right for
Respiratory Tract DiseasesRespiratory HypersensitivityAsthma
Sanofi 1,568
Large-scale testing (Phase 3)Study completedNCT01172808
What this trial is testing

Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma I

Who this might be right for
Asthma
Boehringer Ingelheim 1,071
Large-scale testing (Phase 3)Study completedNCT01172821
What this trial is testing

Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma II

Who this might be right for
Asthma
Boehringer Ingelheim 1,032
Large-scale testing (Phase 3)UnknownNCT03387241
What this trial is testing

Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 Years

Who this might be right for
Asthma
Mundipharma (China) Pharmaceutical Co. Ltd 330
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation